The hidden pitfalls: How smart entrepreneurs misunderstand medical regulations
A consequence of giving talks is that you get approached by a lot of people with innovative ideas and a drive to make them happen. Many need help.

The hidden pitfalls: How smart entrepreneurs misunderstand medical regulations

I keep coming across a perplexing problem: highly intelligent people who, without realising it, inadvertently enter the realm of highly regulated medical products. Despite their brilliance, they often underestimate the complexity of medical regulation and assume that their innovations exist outside of this strict framework.

I recently met a software developer who confidently told me, "I'm not making a medical device, it's just software". He was unaware that software intended for diagnostic or therapeutic purposes is classified as a medical device under regulations such as the EU's Medical Device Regulation (MDR). His oversight could lead to significant legal hurdles and stall the progress of his project.

Another encounter was with a woman who makes her own skin care products. After extensive research using ChatGPT (and, tellingly, not PubMed), she added numerous claims about how her moringa oil provides UV protection, renews, repairs and rejuvenates the skin. She didn't realise that making such health claims requires solid scientific evidence from peer-reviewed studies. Relying solely on informal research not only risks legal repercussions, but also puts consumer safety at risk.

Then there was a highly intelligent businessman who wanted to build a patient-facing health app. He believed that because he wasn't targeting doctors, his app would be a consumer device, free from medical regulation. He overlooked the fact that any software that provides information used to make diagnostic or therapeutic decisions is subject to regulatory scrutiny, regardless of the end user.

What struck me was not just their initial misunderstanding, but their continued denial, even after I pointed out the regulatory complexities. They seemed to think that compliance was something to be figured out along the way. But in the medical field, compliance is not a box to be ticked later; it's the foundation upon which a viable product must be built.

There's a common misconception that innovation thrives on thinking outside the box and defying norms. This mindset often confuses conviction with mere belief. True conviction comes from deep analysis and understanding, not from ignoring established rules. Over-optimism without substance is not a sign of visionary thinking; it's a sign of laziness - and a strategic liability.

Medical innovation doesn't happen in a vacuum. It takes place within a regulatory framework designed to ensure safety and efficacy. Successful entrepreneurs recognise that these constraints are not obstacles, but essential guidelines that, when fully understood, can be used to find creative early commercialisation strategies that are fully compliant.

Understanding regulations such as MDR Rule 11 and guidelines from bodies such as the International Medical Device Regulators Forum (IMDRF) is critical. For example, software designed to provide information for diagnostic or therapeutic decisions is classified as a medical device and must meet specific regulatory requirements.

Similarly, making health-related claims about products such as skin care requires compliance with advertising laws that prohibit false or misleading claims. Claims must be supported by rigorous scientific evidence, not just informal research or anecdotal observations.

Ignoring these regulations isn't just risky; it's a strategic mistake that can kill a business before it starts. Compliance is not an optional hurdle, but a mandatory step that ensures the right to play in the marketplace. It requires thorough understanding and integration into the business strategy from the outset.

In conclusion, I see time and again that even the most intelligent entrepreneurs can misjudge the importance of medical regulations. The key is to replace uninformed belief with informed conviction, using in-depth analysis to navigate the complex regulatory landscape. By embracing regulation as a guiding principle, we can effectively innovate within constraints and turn potential challenges into opportunities for success.

Thank you for the great input in Berlin ?? it was amazing ??

回复
Dr. Sven Jungmann

Helping medical device manufacturers transform products into AI-driven, cloud-connected devices for enhanced compliance, interoperability, and innovation.

1 个月

Nikita Tarasov Check the comments haha

回复
Dr Hugh Harvey

Managing Director, Hardian Health | SaMD and AIaMD consulting

1 个月

There are 5 stages of regulatory grief: Denial - We are not building a medical device (which you write about here perfectly) Anger - What do you mean we can't just write some code and then plug it into a hospital? Bargaining - Surely we don't have to do all this? Can we just pretend to be class I? Depression - We promised our investors a hockey stick return next year.... Acceptance - Gaining regulatory approval will create a moat against those in the other stages of regulatory grief, showcase our commitment to accepted standards and be the building block for trust in our product. Oh, and we can legally sell our product now.

Dr. Sven Jungmann

Helping medical device manufacturers transform products into AI-driven, cloud-connected devices for enhanced compliance, interoperability, and innovation.

1 个月

Inga Bergen looks like this topic resonates quite a bit :-)

回复
Marek Rydzewski

Prozesskritik vor Digitalisierung!

1 个月

I would add one more point: Better understanding of the care and reimbursement structures in the (German) healthcare system

要查看或添加评论,请登录

社区洞察

其他会员也浏览了